{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:40:16Z","timestamp":1791510016298,"version":"4.3.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00403-017-1789-1","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T05:34:29Z","timestamp":1508909669000},"page":"11-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review"],"prefix":"10.1007","volume":"310","author":[{"given":"Ariadne Hadjikyriacou","family":"Saniklidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Tighe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy C.","family":"Fairclough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"1789_CR1","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/jid.2008.80","volume":"128","author":"S Altrichter","year":"2008","unstructured":"Altrichter S, Kriehuber E, Moser J, Valenta R, Kopp T, Stingl G (2008) Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis. J Invest Dermatol 128:2232\u20132239","journal-title":"J Invest Dermatol"},{"key":"1789_CR2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00403-015-1609-4","volume":"308","author":"KT Amber","year":"2016","unstructured":"Amber KT (2016) Is anti-BP180 IgE associated with clinical phenotype? A reply to \u2018Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid\u2019. Arch Dermatol Res 308:65\u201366","journal-title":"Arch Dermatol Res"},{"key":"1789_CR3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archderm.1974.01630090016003","volume":"110","author":"CE Arbesman","year":"1974","unstructured":"Arbesman CE, Wypych JI, Reisman RE, Beutner EH (1974) IgE levels in sera of patients with pemphigus or bullous pemphigoid. Arch Dermatol 110:378\u2013381","journal-title":"Arch Dermatol"},{"key":"1789_CR4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2340\/0001555564243246","volume":"64","author":"E Asbrink","year":"1984","unstructured":"Asbrink E, Hovmark A (1984) Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies. Acta Derm Venereol 64:243\u2013246","journal-title":"Acta Derm Venereol"},{"key":"1789_CR5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4049\/jimmunol.116.1.112","volume":"116","author":"T Baba","year":"1976","unstructured":"Baba T, Sonozaki H, Seki K, Uchiyama M, Ikesawa Y, Toriisu M (1976) An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients. J Immunol 116:112\u2013116","journal-title":"J Immunol"},{"key":"1789_CR6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0190-9622(87)80227-X","volume":"16","author":"P Bernard","year":"1987","unstructured":"Bernard P, Venot J, Constant F, Bonnetblanc JM (1987) Blood eosinophilia as a severity marker for bullous pemphigoid. J Am Acad Dermatol 16:879\u2013881","journal-title":"J Am Acad Dermatol"},{"key":"1789_CR7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00403-015-1598-3","volume":"307","author":"L Bing","year":"2015","unstructured":"Bing L, Xiping Z, Li L, Jun P, Yi-Xia W, Min Y, Qing L, Qiu-Ning S, Hong-Zhong J, Ya-Gang Z (2015) Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid. Arch Dermatol Res 307:849\u2013854","journal-title":"Arch Dermatol Res"},{"key":"1789_CR8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0190-9622(83)70073-3","volume":"8","author":"LL Bushkell","year":"1983","unstructured":"Bushkell LL, Jordon RE (1983) Bullous pemphigoid: a cause of peripheral blood eosinophilia. J Am Acad Dermatol 8:648\u2013651","journal-title":"J Am Acad Dermatol"},{"key":"1789_CR9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40413-016-0130-3","volume":"9","author":"GW Canonica","year":"2016","unstructured":"Canonica GW, Senna G, Mitchell PD, O\u2019Byrne PM, Passalacqua G, Varricchi G (2016) Therapeutic interventions in severe asthma. World Allergy Organ J 9:40","journal-title":"World Allergy Organ J"},{"key":"1789_CR10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaci.2014.04.036","volume":"135","author":"TW Chang","year":"2015","unstructured":"Chang TW, Chen C, Lin CJ, Metz M, Church MK, Maurer M (2015) The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria. J Allergy Clin Immunol 135:337\u2013342","journal-title":"J Allergy Clin Immunol"},{"key":"1789_CR11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jdermsci.2016.03.009","volume":"83","author":"YT Cho","year":"2016","unstructured":"Cho YT, Liao SL, Wang LF, Chu CY (2016) High serum anti-BP180 IgE levels correlate to prominent urticarial lesions in patients with bullous pemphigoid. J Dermatol Sci 83:78\u201380","journal-title":"J Dermatol Sci"},{"key":"1789_CR12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2133.1997.tb14953.x","volume":"136","author":"S Cliff","year":"1997","unstructured":"Cliff S, Holden CA (1997) Pemphigoid nodularis: a report of three cases and review of the literature. Br J Dermatol 136:398\u2013401","journal-title":"Br J Dermatol"},{"key":"1789_CR13","first-page":"293","volume":"25","author":"LB Concha","year":"2004","unstructured":"Concha LB, Chang CC, Szema AM, Dattwyler RJ, Carlson HE (2004) IgE antithyroid antibodies in patients with Hashimoto\u2019s disease and chronic urticaria. Allergy Asthma Proc 25:293\u2013296","journal-title":"Allergy Asthma Proc"},{"key":"1789_CR14","first-page":"317","volume":"15","author":"E Cozzani","year":"2001","unstructured":"Cozzani E, Parodi A, Rebora A, Delmonte S, Barile M, Nigro A, Priano L, Troiano G, Patri PL, Gruppo Liguredi Studi in D (2001) Bullous pemphigoid in Liguria: a 2-year survey. J Eur Acad Dermatol Venereol 15:317\u2013319","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1789_CR15","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.4049\/jimmunol.157.8.3642","volume":"157","author":"E Delaporte","year":"1996","unstructured":"Delaporte E, Dubost-Brama A, Ghohestani R, Nicolas JF, Neyrinck JL, Bergoend H, Janin A, Capron M (1996) IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid. J Immunol 157:3642\u20133647","journal-title":"J Immunol"},{"key":"1789_CR16","doi-asserted-by":"crossref","first-page":"e90424","DOI":"10.1371\/journal.pone.0090424","volume":"9","author":"B Dema","year":"2014","unstructured":"Dema B, Pellefigues C, Hasni S, Gault N, Jiang C, Ricks TK, Bonelli MM, Scheffel J, Sacr\u00e9 K, Jablonski M, Gobert D, Papo T, Daugas E, Illei G, Charles N, Rivera J (2014) Autoreactive IgE Is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis. PLoS ONE 9:e90424","journal-title":"PLoS ONE"},{"key":"1789_CR17","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1523-1747.2003.12146.x","volume":"120","author":"OG Dimson","year":"2003","unstructured":"Dimson OG, Giudice GJ, Fu CL, Van den Bergh F, Warren SJ, Janson MM, Fairley JA (2003) Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. J Invest Dermatol 120:784\u2013788","journal-title":"J Invest Dermatol"},{"key":"1789_CR18","first-page":"577","volume":"42","author":"R Dopp","year":"2000","unstructured":"Dopp R, Schmidt E, Chimanovitch I, Leverkus M, Brocker EB, Zillikens D (2000) IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol 42:577\u2013583","journal-title":"J Am Acad Dermatol"},{"key":"1789_CR19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2133.2008.08858.x","volume":"160","author":"SK Dresow","year":"2009","unstructured":"Dresow SK, Sitaru C, Recke A, Oostingh GJ, Zillikens D, Gibbs BF (2009) IgE autoantibodies against the intracellular domain of BP180. Br J Dermatol 160:429\u2013432","journal-title":"Br J Dermatol"},{"key":"1789_CR20","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1365-2133.2011.10748.x","volume":"166","author":"C Dufour","year":"2012","unstructured":"Dufour C, Souillet AL, Chaneliere C, Jouen F, Bodemer C, Jullien D, Cambazard F, Joly P, Reix P (2012) Successful management of severe infant bullous pemphigoid with omalizumab. Br J Dermatol 166:1140\u20131142","journal-title":"Br J Dermatol"},{"key":"1789_CR21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","volume":"123","author":"JA Fairley","year":"2009","unstructured":"Fairley JA, Baum CL, Brandt DS, Messingham KA (2009) Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab. J Allergy Clin Immunol 123:704\u2013705","journal-title":"J Allergy Clin Immunol"},{"key":"1789_CR22","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/sj.jid.5700958","volume":"127","author":"JA Fairley","year":"2007","unstructured":"Fairley JA, Burnett CT, Fu CL, Larson DL, Fleming MG, Giudice GJ (2007) A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu\/nu mice. J Invest Dermatol 127:2605\u20132611","journal-title":"J Invest Dermatol"},{"key":"1789_CR23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.0022-202X.2005.23853.x","volume":"125","author":"JA Fairley","year":"2005","unstructured":"Fairley JA, Fu CL, Giudice GJ (2005) Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid. J Invest Dermatol 125:467\u2013472","journal-title":"J Invest Dermatol"},{"key":"1789_CR24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0923-1811(94)90089-2","volume":"7","author":"F Furukawa","year":"1994","unstructured":"Furukawa F, Kumagai S, Sakamoto Y, Takigawa M, Imamura S (1994) Elevated serum levels of IgE-binding factor\/soluble CD23 in bullous pemphigoid. J Dermatol Sci 7:150\u2013154","journal-title":"J Dermatol Sci"},{"key":"1789_CR25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1023\/A:1020531005776","volume":"18","author":"RF Ghohestani","year":"1998","unstructured":"Ghohestani RF, Cozzani E, Delaporte E, Nicolas JF, Parodi A, Claudy A (1998) IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230). J Clin Immunol 18:202\u2013209","journal-title":"J Clin Immunol"},{"key":"1789_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjd.15114","volume":"177","author":"T Hashimoto","year":"2016","unstructured":"Hashimoto T, Ohzono A, Teye K, Numata S, Hiroyasu S, Tsuruta D, Hachiya T, Kuroda K, Hashiguchi M, Kawakami T, Ishii N (2016) Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid. Br J Dermatol 177:141\u2013151","journal-title":"Br J Dermatol"},{"key":"1789_CR27","doi-asserted-by":"crossref","first-page":"13739","DOI":"10.1074\/jbc.271.23.13739","volume":"271","author":"Y Hirako","year":"1996","unstructured":"Hirako Y, Usukura J, Nishizawa Y, Owaribe K (1996) Demonstration of the molecular shape of BP180, a 180-kDa bullous pemphigoid antigen and its potential for trimer formation. J Biol Chem 271:13739\u201313745","journal-title":"J Biol Chem"},{"key":"1789_CR28","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4049\/jimmunol.1100596","volume":"187","author":"M Hirose","year":"2011","unstructured":"Hirose M, Recke A, Beckmann T, Shimizu A, Ishiko A, Bieber K, Westermann J, Zillikens D, Schmidt E, Ludwig RJ (2011) Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice. J Immunol 187:1176\u20131183","journal-title":"J Immunol"},{"key":"1789_CR29","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/jid.2014.25","volume":"134","author":"S Hradetzky","year":"2014","unstructured":"Hradetzky S, Roesner LM, Balaji H, Heratizadeh A, Mittermann I, Valenta R, Werfel T (2014) Cytokine effects induced by the human autoallergen alpha-NAC. J Invest Dermatol 134:1570\u20131578","journal-title":"J Invest Dermatol"},{"key":"1789_CR30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s40629-015-0037-5","volume":"24","author":"S Hradetzky","year":"2015","unstructured":"Hradetzky S, Werfel T, Rosner LM (2015) Autoallergy in atopic dermatitis. Allergo J Int 24:16\u201322","journal-title":"Allergo J Int"},{"key":"1789_CR31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2007.08.008","volume":"49","author":"N Ishiura","year":"2008","unstructured":"Ishiura N, Fujimoto M, Watanabe R, Nakashima H, Kuwano Y, Yazawa N, Echigo T, Okochi H, Tamaki K (2008) Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 49:153\u2013161","journal-title":"J Dermatol Sci"},{"key":"1789_CR32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archdermatol.2007.9","volume":"144","author":"Y Iwata","year":"2008","unstructured":"Iwata Y, Komura K, Kodera M, Usuda T, Yokoyama Y, Hara T, Muroi E, Ogawa F, Takenaka M, Sato S (2008) Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid. Arch Dermatol 144:41\u201348","journal-title":"Arch Dermatol"},{"key":"1789_CR33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","volume":"346","author":"P Joly","year":"2002","unstructured":"Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, Vaillant L, D\u2019Incan M, Plantin P, Bedane C, Young P, Bernard P, Bullous Diseases French Study G (2002) A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 346:321\u2013327","journal-title":"N Engl J Med"},{"key":"1789_CR34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2340\/00015555-2101","volume":"96","author":"M Kalowska","year":"2016","unstructured":"Kalowska M, Ciepiela O, Kowalewski C, Demkow U, Schwartz RA, Wozniak K (2016) Enzyme-linked immunoassay index for anti-NC16a IgG and IgE auto-antibodies correlates with severity and activity of bullous pemphigoid. Acta Derm Venereol 96:191\u2013196","journal-title":"Acta Derm Venereol"},{"key":"1789_CR35","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/j.jaci.2006.12.167","volume":"119","author":"LA Kelly","year":"2007","unstructured":"Kelly LA, Holubkov R, Campbell MA, Herlevi KS, Taylor T, Hull C, Gleich GJ, Zone JJ, Leiferman KM (2007) Serum IgE concentrations in bullous pemphigoid correlate with disease activity. J Allergy Clin Immunol 119:S204","journal-title":"J Allergy Clin Immunol"},{"key":"1789_CR36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1067\/mai.2002.123303","volume":"109","author":"T Kinaciyan","year":"2002","unstructured":"Kinaciyan T, Natter S, Kraft D, Stingl G, Valenta R (2002) IgE autoantibodies monitored in a patient with atopic dermatitis under cyclosporin A treatment reflect tissue damage. J Allergy Clin Immunol 109:717\u2013719","journal-title":"J Allergy Clin Immunol"},{"key":"1789_CR37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/cea.12673","volume":"46","author":"P Kolkhir","year":"2016","unstructured":"Kolkhir P, Pogorelov D, Olisova O, Maurer M (2016) Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus\u2014a systematic review. Clin Exp Allergy 46:275\u2013287","journal-title":"Clin Exp Allergy"},{"key":"1789_CR38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jdermsci.2015.02.015","volume":"78","author":"L Ma","year":"2015","unstructured":"Ma L, Wang M, Wang X, Chen X, Zhu X (2015) Circulating IgE anti-BP180 autoantibody and its correlation to clinical and laboratorial aspects in bullous pemphigoid patients. J Dermatol Sci 78:76\u201377","journal-title":"J Dermatol Sci"},{"key":"1789_CR39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jim.2009.04.013","volume":"346","author":"KA Messingham","year":"2009","unstructured":"Messingham KA, Noe MH, Chapman MA, Giudice GJ, Fairley JA (2009) A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid. J Immunol Methods 346:18\u201325","journal-title":"J Immunol Methods"},{"key":"1789_CR40","doi-asserted-by":"crossref","first-page":"e107725","DOI":"10.1371\/journal.pone.0107725","volume":"9","author":"KN Messingham","year":"2014","unstructured":"Messingham KN, Holahan HM, Frydman AS, Fullenkamp C, Srikantha R, Fairley JA (2014) Human eosinophils express the high affinity IgE receptor, FcepsilonRI, in bullous pemphigoid. PLoS ONE 9:e107725","journal-title":"PLoS ONE"},{"key":"1789_CR41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4049\/jimmunol.1001753","volume":"187","author":"KN Messingham","year":"2011","unstructured":"Messingham KN, Srikantha R, DeGueme AM, Fairley JA (2011) FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid. J Immunol 187:553\u2013560","journal-title":"J Immunol"},{"key":"1789_CR42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2015.01.013","volume":"78","author":"R Moriuchi","year":"2015","unstructured":"Moriuchi R, Nishie W, Ujiie H, Natsuga K, Shimizu H (2015) In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases. J Dermatol Sci 78:21\u201325","journal-title":"J Dermatol Sci"},{"key":"1789_CR43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0923-1811(01)00084-6","volume":"25","author":"Y Muro","year":"2001","unstructured":"Muro Y (2001) Autoantibodies in atopic dermatitis. J Dermatol Sci 25:171\u2013178","journal-title":"J Dermatol Sci"},{"key":"1789_CR44","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archderm.1980.01640290065013","volume":"116","author":"C Nieboer","year":"1980","unstructured":"Nieboer C, van Leeuwen HJ (1980) IgE in the serum and on mast cells in bullous pemphigoid. Arch Dermatol 116:555\u2013556","journal-title":"Arch Dermatol"},{"key":"1789_CR45","first-page":"245","volume":"86C","author":"H Permin","year":"1978","unstructured":"Permin H, Wiik A (1978) The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus. Acta Pathol Microbiol Scand C 86C:245\u2013249","journal-title":"Acta Pathol Microbiol Scand C"},{"key":"1789_CR46","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/bjd.12161","volume":"168","author":"D Pomponi","year":"2013","unstructured":"Pomponi D, Di Zenzo G, Zennaro D, Calabresi V, Eming R, Zuzzi S, Bernardi ML, Scala E, Mari A (2013) Detection of IgG and IgE reactivity to BP180 using the ISAC(R) microarray system. Br J Dermatol 168:1205\u20131214","journal-title":"Br J Dermatol"},{"key":"1789_CR47","first-page":"193","volume":"18","author":"TT Provost","year":"1974","unstructured":"Provost TT, Tomasi TB Jr (1974) Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin. Clin Exp Immunol 18:193\u2013200","journal-title":"Clin Exp Immunol"},{"key":"1789_CR48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","volume":"134","author":"JC Roujeau","year":"1998","unstructured":"Roujeau JC, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P (1998) High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 134:465\u2013469","journal-title":"Arch Dermatol"},{"key":"1789_CR49","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jaci.2016.04.007","volume":"137","author":"MA Sanjuan","year":"2016","unstructured":"Sanjuan MA, Sagar D, Kolbeck R (2016) Role of IgE in autoimmunity. J Allergy Clin Immunol 137:1651\u20131661","journal-title":"J Allergy Clin Immunol"},{"key":"1789_CR50","first-page":"3602","volume":"84","author":"A Sato","year":"1999","unstructured":"Sato A, Takemura Y, Yamada T, Ohtsuka H, Sakai H, Miyahara Y, Aizawa T, Terao A, Onuma S, Junen K, Kanamori A, Nakamura Y, Tejima E, Ito Y, Kamijo K (1999) A possible role of immunoglobulin E in patients with hyperthyroid Graves\u2019 disease. J Clin Endocrinol Metab 84:3602\u20133605","journal-title":"J Clin Endocrinol Metab"},{"key":"1789_CR51","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/archderm.1995.01690200106030","volume":"131","author":"E Schmidt","year":"1995","unstructured":"Schmidt E, Brocker EB, Zillikens D (1995) High levels of soluble CD23 in blister fluid of patients with bullous pemphigoid. Arch Dermatol 131:966\u2013967","journal-title":"Arch Dermatol"},{"key":"1789_CR52","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt E, Zillikens D (2013) Pemphigoid diseases. Lancet 381:320\u2013332","journal-title":"Lancet"},{"key":"1789_CR53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0065-2776(08)60503-9","volume":"53","author":"JR Stanley","year":"1993","unstructured":"Stanley JR (1993) Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol 53:291\u2013325","journal-title":"Adv Immunol"},{"issue":"1209\u20131215","key":"1789_CR54","first-page":"e2","volume":"129","author":"TS Tang","year":"2012","unstructured":"Tang TS, Bieber T, Williams HC (2012) Does \u201cautoreactivity\u201d play a role in atopic dermatitis? J Allergy Clin Immunol 129(1209\u20131215):e2","journal-title":"J Allergy Clin Immunol"},{"key":"1789_CR55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jdermsci.2004.10.007","volume":"37","author":"Y Tsuji-Abe","year":"2005","unstructured":"Tsuji-Abe Y, Akiyama M, Yamanaka Y, Kikuchi T, Sato-Matsumura KC, Shimizu H (2005) Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid. J Dermatol Sci 37:145\u2013149","journal-title":"J Dermatol Sci"},{"key":"1789_CR56","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1046\/j.1523-1747.1998.00413.x","volume":"111","author":"R Valenta","year":"1998","unstructured":"Valenta R, Natter S, Seiberler S, Wichlas S, Maurer D, Hess M, Pavelka M, Grote M, Ferreira F, Szepfalusi Z, Valent P, Stingl G (1998) Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients. J Invest Dermatol 111:1178\u20131183","journal-title":"J Invest Dermatol"},{"key":"1789_CR57","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamadermatol.2016.3357","volume":"153","author":"N Beek van","year":"2017","unstructured":"van Beek N, Luttmann N, Huebner F, Recke A, Karl I, Schulze FS, Zillikens D, Schmidt E (2017) Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity. JAMA Dermatol 153:30\u201338","journal-title":"JAMA Dermatol"},{"key":"1789_CR58","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/bjd.12072","volume":"167","author":"VA Venning","year":"2012","unstructured":"Venning VA, Taghipour K, Mohd Mustapa MF, Highet AS, Kirtschig G (2012) British association of dermatologists\u2019 guidelines for the management of bullous pemphigoid 2012. Br J Dermatol 167:1200\u20131214","journal-title":"Br J Dermatol"},{"key":"1789_CR59","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-2133.2011.10481.x","volume":"165","author":"S Yayli","year":"2011","unstructured":"Yayli S, Pelivani N, Beltraminelli H, Wirthmuller U, Beleznay Z, Horn M, Borradori L (2011) Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis. Br J Dermatol 165:1133\u20131137","journal-title":"Br J Dermatol"},{"key":"1789_CR60","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaad.2014.04.053","volume":"71","author":"KK Yu","year":"2014","unstructured":"Yu KK, Crew AB, Messingham KA, Fairley JA, Woodley DT (2014) Omalizumab therapy for bullous pemphigoid. J Am Acad Dermatol 71:468\u2013474","journal-title":"J Am Acad Dermatol"},{"key":"1789_CR61","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaci.2009.05.015","volume":"124","author":"S Zeller","year":"2009","unstructured":"Zeller S, Rhyner C, Meyer N, Schmid-Grendelmeier P, Akdis CA, Crameri R (2009) Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema. J Allergy Clin Immunol 124:278\u2013285","journal-title":"J Allergy Clin Immunol"},{"key":"1789_CR62","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.jid.5700681","volume":"127","author":"JJ Zone","year":"2007","unstructured":"Zone JJ, Taylor T, Hull C, Schmidt L, Meyer L (2007) IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice. J Invest Dermatol 127:1167\u20131174","journal-title":"J Invest Dermatol"},{"key":"1789_CR63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00403-015-1610-y","volume":"308","author":"Y Zuo","year":"2016","unstructured":"Zuo Y (2016) Is anti-BP180 IgE associated with clinical phenotype? Reply to the letter to the editor. Arch Dermatol Res 308:67\u201368","journal-title":"Arch Dermatol Res"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-017-1789-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-017-1789-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-017-1789-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T20:48:12Z","timestamp":1719521292000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-017-1789-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1789"],"URL":"https:\/\/doi.org\/10.1007\/s00403-017-1789-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734288641.793560319","asserted-by":"object"}]},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]}}}